Markets Gone Wild

Exciting Breakthrough in Cancer Treatment Groundbreaking Results for MTAP-Deletion Patients Recently, IDEAYA Biosciences, Inc. announced Phase 1 expansion data for IDE397 in heavily pre-treated MTAP-deletion urothelial cancer (UC) and non-small cell lung cancer (NSCLC) patients. The results were presented at the 36th EORTC-NCI-AACR Symposium in Barcelona, Spain, as a late breaker abstract (LBA) oral presentation….

Welcome to my unconventional take on Nutanix’s Q1 results! Shares of Nutanix fell ~8% after reporting Q1 results Despite beating Street expectations and raising full-year estimates Nutanix, a leader in enterprise cloud computing, faced a minor setback in its stock price after an impressive Q1 performance that exceeded Wall Street’s forecasts. The company reported a…

Class Action Lawsuit Reminder for Elanco Animal Health Incorporated Don’t Let Your Investments Go to the Dogs! Hey there, fellow investors! Have you heard about the latest class action lawsuit against Elanco Animal Health Incorporated? If not, you might want to pay attention, especially if you’ve purchased the company’s securities between November 7, 2023 and…

Investor Alert: Class Action Lawsuit Filed Against Orthofix Medical Inc. and SeaSpine Holdings Corporation New York City, NY / October 16, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, has notified investors of a class action lawsuit filed against Orthofix Medical Inc. (“Orthofix”) and certain current and former officers and directors…

AVY Expects Strong Earnings Growth in 2025 As a company that prides itself on being prossionally run, educated in the market, profit focused, and intense in its pursuit of success, AVY’s latest earnings forecast for 2025 has sent shockwaves through the business world. The company expects adjusted earnings per share of $9.80-$10.20, signaling a significant…

Zedcor Inc. reports strong financial and operating results for Q2 2024 Calgary, Alberta–(Newsfile Corp. – August 13, 2024) Zedcor Inc. (TSXV: ZDC) (“Zedcor” or the “Company”) today announced its financial and operating results for the three and six months ended June 30, 2024. Highlights of the report include the following: – Record quarterly revenue of…